• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- (CAS No. 2092339-57-4): A Comprehensive Overview

Piperidine, 1-(3-ethyl-3-pyrrolidinyl)-, identified by the CAS number 2092339-57-4, is a significant compound in the realm of pharmaceutical chemistry and drug development. This compound belongs to the piperidine class of heterocyclic amines, which are widely recognized for their diverse biological activities and pharmacological properties. The unique structural features of Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- make it a valuable intermediate in the synthesis of various therapeutic agents.

The molecular structure of Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- consists of a piperidine ring substituted with a 3-ethyl-3-pyrrolidinyl group. This configuration imparts distinct chemical and biological characteristics that have garnered interest from researchers in the pharmaceutical industry. The presence of both piperidine and pyrrolidinyl moieties enhances its potential as a building block for complex molecular architectures, facilitating the development of novel drugs targeting various diseases.

In recent years, there has been a surge in research focused on developing new therapeutic agents with improved efficacy and reduced side effects. Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- has emerged as a key intermediate in this endeavor. Its structural motif is found in several pharmacologically active compounds, making it a subject of extensive investigation. Researchers have explored its utility in synthesizing molecules with potential applications in treating neurological disorders, cardiovascular diseases, and infectious diseases.

One of the most compelling aspects of Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- is its role in the development of central nervous system (CNS) therapeutics. Piperidine derivatives are known for their ability to cross the blood-brain barrier, a crucial property for drugs targeting neurological conditions. The 3-ethyl-3-pyrrolidinyl substituent further enhances its pharmacokinetic profile, making it an attractive candidate for further exploration.

Recent studies have highlighted the potential of Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- in the development of antiviral agents. The unique structural features of this compound allow it to interact with viral enzymes and proteins, inhibiting their function and thereby reducing viral replication. Preliminary research suggests that derivatives of this compound may be effective against a range of viruses, including those responsible for influenza and HIV.

The synthesis of Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advanced synthetic methodologies, such as transition metal-catalyzed reactions and asymmetric synthesis, have been employed to enhance the efficiency of its production. These techniques not only improve the scalability of the synthesis but also allow for the introduction of additional functional groups, expanding its utility in drug design.

The pharmacological properties of Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- have been extensively studied in preclinical models. These studies have revealed its potential as an antagonist for various receptors and enzymes involved in disease pathways. For instance, derivatives of this compound have shown promise in treating conditions such as depression and anxiety by modulating neurotransmitter systems.

In addition to its therapeutic applications, Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- has been explored for its role in chemical biology research. Its ability to serve as a scaffold for designing novel molecules has made it a valuable tool for understanding biological processes at the molecular level. By studying how this compound interacts with biological targets, researchers can gain insights into disease mechanisms and develop more targeted therapies.

The future prospects for Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- are promising, with ongoing research aimed at expanding its applications in drug development. Innovations in synthetic chemistry and computational modeling are expected to further enhance its utility as an intermediate for producing next-generation pharmaceuticals. Collaborative efforts between academia and industry are likely to drive advancements that could lead to new treatments for unmet medical needs.

In conclusion, Piperidine, 1-(3-ethyl-3-pyrrolidinyl)- (CAS No. 2092339-57-4) is a versatile compound with significant potential in pharmaceutical research and drug development. Its unique structural features and diverse biological activities make it a valuable asset in the quest for novel therapeutic agents. As research continues to uncover new applications for this compound, it is poised to play an increasingly important role in addressing some of the most pressing challenges in medicine today.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)